You are here

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2020 to January 2026

AbstractFullPdf
Dec 2020376376175
Jan 202117117189
Feb 202110410455
Mar 202111011074
Apr 2021817951
May 2021636342
Jun 202111011046
Jul 2021787851
Aug 2021616136
Sep 2021949474
Oct 2021797968
Nov 2021787884
Dec 2021878968
Jan 2022707359
Feb 2022434537
Mar 202211412068
Apr 202210310456
May 2022838552
Jun 2022636535
Jul 2022595915
Aug 2022666651
Sep 2022364028
Oct 2022515642
Nov 2022424233
Dec 2022373821
Jan 2023393923
Feb 2023747429
Mar 2023717257
Apr 2023242423
May 2023323213
Jun 2023292912
Jul 2023505127
Aug 2023313318
Sep 2023545424
Oct 2023383826
Nov 2023535529
Dec 2023545427
Jan 2024272831
Feb 2024454556
Mar 2024505057
Apr 2024464747
May 2024464726
Jun 2024383730
Jul 2024444630
Aug 2024363822
Sep 2024343518
Oct 2024353520
Nov 2024717233
Dec 2024757544
Jan 2025535325
Feb 202510710747
Mar 2025474735
Apr 2025494929
May 2025373727
Jun 2025262715
Jul 2025110
Jan 2026110
Total367637172310